ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Deka International SA

Deka International SA (DEDQ)

75.493
0.501
(0.67%)
Cerrado 05 Enero 3:00PM
Realtime Data

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
75.493
Postura de Compra
75.128
Postura de Venta
75.857
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
74.992
Precio de Apertura
-
Hora
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

DEDQ Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000FU
40000000FU
120000000FU
260000000FU
520000000FU
1560000000FU
2600000000FU

DEDQ - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Deka?
El precio actual de las acciones de Deka es 75.493 €
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Deka?
Deka ha negociado en un rango de 0.00 € a 0.00 € durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
0S6Cerence Inc
18.972 €
(145.34%)
90.04k
CY9DMicrobot Medical Inc
2.11 €
(89.07%)
24.21k
RV0Torrent Gold Inc
0.138 €
(73.58%)
1.23k
7CCCheckCap Ltd
1.76 €
(55.75%)
6.55k
34Q0Quantum eMotion Inc
0.985 €
(53.91%)
1.62M
7DBDiamondback Energy Inc
9.7176 €
(-94.02%)
800
FASFastenal Co
9.7358 €
(-85.95%)
2.13k
1UR1Bee Vectoring Technologies International Inc
0.003 €
(-45.45%)
300.18k
B4T0CuFe Ltd
0.0045 €
(-25.00%)
1
H5EHelma Eigenheimbau Ag
0.0766 €
(-23.40%)
751
PF8European Lithium Limited
0.0264 €
(8.20%)
5.76M
3CPXiaomi Corporation
4.597 €
(7.34%)
3.95M
D7GNel ASA
0.247 €
(2.66%)
2.33M
J9AVERSES AI Inc
1.352 €
(0.00%)
1.67M
34Q0Quantum eMotion Inc
0.985 €
(53.91%)
1.62M
devil dog 96 devil dog 96 3 minutos hace
Tell everyone why you think they never took the 39 million shares off restriction if they need shares to dump? Why have they not taken 1 share off restriction since early 2021 if they need shares to dump?? Why would they issue new shares that will be unregistered and also have to wait a year before
ATMH
CrossFireTrader CrossFireTrader 3 minutos hace
Page 22 of 26, and If say I'm Bullish that'll set 280e off, and I'll  be accused of pumping our little lottery ticket. I'm here for the long haul. I'm not here to sell at 0.016 or 0.02 or 0.03 or whatever his new price is. He actually likes GDVM a lot more than he lets on. Since you seem to be somew
GDVM
Mr. Bill Mr. Bill 7 minutos hace
https://measuringmyhealth.com/what-is-a-normal-pi-on-a-pulse-oximeter/
georgejjl georgejjl 7 minutos hace
That is WRONG. The current standard of care is donepezil (Aricept) and memantine, etc.

MAB's still are an extremely small number of treatments for Alzheimer's in the USA and worldwide.

Good luck and GOD bless,
AVXL
axelvento axelvento 27 minutos hace
Q1 the first interim analysis of the vaccine’s efficacy is expected

Moderna’s mRNA-1647
Cytomegalovirus
MRNA
MightyX MightyX 30 minutos hace
Yet no one is innocent
TPTW
BIG D 4 BIG D 4 31 minutos hace
WOW !! HAPPY NEW YEAR TO ALL THE LONGS HERE !! I HAVE 2 NAYSAYERS ON IGNORE SO I NEVER READ THEIR BS !! GO SAVING GRACE-- JJ AND ALL THE NEW POSTERS WHO ARE POSITIVE !! .02 CENTS TO START THE RUN TO ONE DOLLAR IS WHERE WE SHOULD BE !! THIS STOCK IS SUCH A GREAT BUY HERE !! I AM LOADED WITH 32 MILLI
MJNA
MightyX MightyX 31 minutos hace
The judicial system legitimizes prosecution
TPTW
jondoeuk jondoeuk 32 minutos hace
A new paper. From it: 'BNT221 was well tolerated across both DLs, with no dose-limiting toxicities of grade 3 or higher attributed to the T cell product observed. Specifically, no cytokine release, immune effector cell-associated neurotoxicity or macrophage activation syndromes were reported. A dose
BNTX
benz280c benz280c 34 minutos hace
Nice to see you are bullish. This quote may round out your knowledge.
"It is worthy to note that a new CUSIP has been approved by the CUSIP Global Services (CGS).
Subsequently, we have submitted a corporation action with FINRA for a Company name change, Ticker Symbol Change and Cusip
GDVM
shajandr shajandr 35 minutos hace
Sorry to read that you're still feeling sick. I posted a week or two ago about 41 bunnies and also some cats and dogs that were rescued from a home in Delaware county, Iowa and that were transferred to the DBQ county animal shelter. I just spoke with DaSqu_w and she went to the animal shelter to see
Lakota-45 Lakota-45 36 minutos hace
Will do, but I doubt they will listen !!!

~ Lol !!!
IONI
boi568 boi568 37 minutos hace
Probably
AVXL
HokieHead HokieHead 39 minutos hace
Wrong..
TWOH
HokieHead HokieHead 39 minutos hace
Get your facts straight, the halt was in the Canadian side as they are reviewing all the disclosures submitted, there’s ZERO issues in the US, it’s a fully reporting SEC company.
TWOH
Lakota-45 Lakota-45 41 minutos hace
I agree with you 'farmI1234 !!!

I'm pretty sure most of the Savvy Investors, that have been paying attention,
have been loading the dips, and .0004's, for a while now.
I know I have, along with fishing down stream.

I doubt any Longs will get caught short,
WDLF
CaptHowdy CaptHowdy 42 minutos hace
RECOMMENDED.... nothing is offical yet, unnecessary twisting of facts to bolster your negative viewpoints. Thats news is two months old
GRLT
axelvento axelvento 43 minutos hace
Cancer vaccines: What’s ahead in 2025

The spotlight is on mRNA-4157 (V940)

https://gulfnews.com/special-reports/cancer-vaccines-whats-ahead-in-2025-1.500010233
MRNA
facts_matter14 facts_matter14 43 minutos hace
Does this sound like a company with 16 products and a 17th on the way?

https://investorshub.advfn.com/uimage/uploads/2024/12/24/mwowsIMG_6034.png








.
SRMX
HomerRomer HomerRomer 44 minutos hace
More testimony videos from trial participants like the Australian news reel of Ern Heaven would be amazing. I would think that most of the people involved 9 years ago in the earlier phase studies have passed on since the average life expectancy is normally between 3-11 years after being diagnosed w
AVXL
CaptHowdy CaptHowdy 45 minutos hace
That's how to make money on the OTC. 🤦🏻‍♂️ Anyone could do it; only if the effort spent discounting the new leadership in place along with the turn around story underway was used to turn a profit vs. using 9yr old DD to bad mouth new CEO.
GRLT
crescentmotor crescentmotor 45 minutos hace
I think that is a bad precedent to start.

100% on parading a handful of Blarcamesine patients at the JPM conference. I highly doubt AVXL would involve itself with anecdotal gimmicks where there is no way possible to extrapolate isolated successes to meaningful conclusions about broad
AVXL JPM
Steady_T Steady_T 48 minutos hace
MABS are the current standard of care, so Blarcamesine has to be better than the MABS, which is not saying much.

I suspect that if Blarcamesine was the equal of the MABS is would still be approved on safety and cost grounds.

As has been pointed out multiple times on the
AVXL

Su Consulta Reciente

Delayed Upgrade Clock